Related Experiment Videos
Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma
Chest
|May 1, 1987
Summary
Patients with allergic rhinitis who are hyperresponsive to methacholine inhalation challenges face a higher risk of developing asthma. This bronchial hyperresponsiveness can indicate future asthma development in allergic rhinitis patients.
Area of Science:
- Pulmonology
- Allergy and Immunology
Background:
- Allergic rhinitis is a common condition.
- Asthma is a chronic respiratory disease.
- Predicting asthma development in allergic rhinitis patients is clinically important.
Purpose of the Study:
- To determine if methacholine inhalation challenge can predict asthma development in patients with allergic rhinitis.
- To assess the long-term risk of asthma in allergic rhinitis patients based on bronchial responsiveness.
Main Methods:
- Prospective study of ragweed-sensitive patients over 4-5 years.
- Methacholine inhalation challenge performed at baseline and follow-up.
- Assessment of bronchial hyperresponsiveness using methacholine.
Main Results:
- 16 of 40 patients (40%) showed methacholine hyperresponsiveness initially.
- Three of these 16 patients (19%) developed asthma within 1.5-5 years.
- No patients with normal baseline methacholine response developed asthma.
- Degree of hyperresponsiveness (PD20) did not predict which responders would develop asthma.
Conclusions:
- Allergic rhinitis patients with methacholine hyperresponsiveness are at significantly greater risk of developing asthma.
- Normal bronchial challenge responses in allergic rhinitis patients indicate a low risk for asthma development.